SPY304.49+1.52 0.50%
DIA254.45+0.10 0.04%
IXIC9,489.87+120.88 1.29%

UBS Upgrades Cardinal Health to Buy, Announces $64 Price Target

UBS analyst Kevin Caliendo upgrades Cardinal Health (NYSE:CAH) from Neutral to Buy and announces $64 price target.

Benzinga · 05/15/2020 11:49

UBS analyst Kevin Caliendo upgrades Cardinal Health (NYSE:CAH) from Neutral to Buy and announces $64 price target.